Anders Frid

6.2k total citations · 2 hit papers
66 papers, 4.9k citations indexed

About

Anders Frid is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Anders Frid has authored 66 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Anders Frid's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (18 papers) and Metabolism, Diabetes, and Cancer (15 papers). Anders Frid is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (18 papers) and Metabolism, Diabetes, and Cancer (15 papers). Anders Frid collaborates with scholars based in Sweden, United Kingdom and Denmark. Anders Frid's co-authors include Inger Björck, Jens J. Holst, Maria Düring, Kjeld Hermansen, Michael A. Nauck, Mikael Nilsson, Kenneth Strauss, David R. Matthews, Ismail Mitha and Tsvetalina Tankova and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

Anders Frid

64 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

2008 939 citations Michael A. Nauck, Anders Frid et al. profile →
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

2017 529 citations Marcus Lind, William H. Polonsky et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Frid Sweden	32	3.3k	1.3k	1.1k	982	869	66	4.9k
Henrik Vestergaard Denmark	43	1.6k 0.5×	1.3k 1.0×	3.3k 3.1×	588 0.6×	1.5k 1.7×	157	6.5k
Albert Goday Spain	43	1.5k 0.5×	1.7k 1.3×	707 0.7×	363 0.4×	1.5k 1.7×	204	5.4k
L Papoz France	32	2.1k 0.6×	627 0.5×	651 0.6×	648 0.7×	477 0.5×	100	4.0k
Jaroslav A. Hubáček Czechia	35	1.2k 0.4×	1.6k 1.2×	1.3k 1.2×	848 0.9×	548 0.6×	294	5.3k
Olga Vaccaro Italy	34	3.1k 1.0×	1.2k 0.9×	1.0k 1.0×	359 0.4×	1.0k 1.2×	126	6.2k
Ashok Balasubramanyam United States	36	1.7k 0.5×	1.0k 0.8×	1.1k 1.0×	1.4k 1.5×	1.0k 1.2×	162	4.6k
Francisco J. Gómez‐Pérez Mexico	34	1.5k 0.5×	599 0.5×	868 0.8×	401 0.4×	762 0.9×	147	3.8k
John D. Bagdade United States	34	2.5k 0.8×	1.6k 1.2×	879 0.8×	640 0.7×	851 1.0×	103	5.1k
Jean‐Philippe Bastard France	35	1.1k 0.3×	621 0.5×	1.4k 1.3×	474 0.5×	2.3k 2.7×	100	7.0k
Thomas A. Buchanan United States	50	2.8k 0.9×	2.5k 1.9×	1.7k 1.6×	833 0.8×	1.5k 1.7×	124	8.8k

Countries citing papers authored by Anders Frid

Since Specialization

Citations

This map shows the geographic impact of Anders Frid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Frid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Frid more than expected).

Fields of papers citing papers by Anders Frid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Frid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Frid. The network helps show where Anders Frid may publish in the future.

Co-authorship network of co-authors of Anders Frid

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Frid. A scholar is included among the top collaborators of Anders Frid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Frid. Anders Frid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nyman, Ulf, Peter Aspelin, Torkel B. Brismar, et al.. (2018). Preventing contrast medium-induced acute kidney injury. European Radiology. 28(12). 5384–5395. 32 indexed citations

Kalra, Sanjay, Laurence Hirsch, Anders Frid, Asma Deeb, & Kenneth Strauss. (2018). Pediatric Insulin Injection Technique: A Multi-Country Survey and Clinical Practice Implications. Diabetes Therapy. 9(6). 2291–2302. 9 indexed citations

Lind, Marcus, William H. Polonsky, Irl B. Hirsch, et al.. (2017). Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. JAMA. 317(4). 379–379. 529 indexed citations breakdown →

Frid, Anders, Gillian Kreugel, G. Grassi, et al.. (2016). New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 91(9). 1231–1255. 197 indexed citations

Costigliola, Vincenzo, Anders Frid, C. Letondeur, & Kenneth Strauss. (2012). Needlestick injuries in European nurses in diabetes. Diabetes & Metabolism. 38. S9–S14. 31 indexed citations

Pikwer, Andreas, E. Vernersson, Anders Frid, & Gunnar Sterner. (2011). Extreme lactic acidosis type B associated with metformin treatment. Clinical Kidney Journal. 4(6). 399–401. 4 indexed citations

Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2011). Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabetic Medicine. 28(10). 1158–1167. 131 indexed citations

Frid, Anders, Laurence Hirsch, Debbie Hicks, et al.. (2010). New injection recommendations for patients with diabetes. Diabetes & Metabolism. 36. S3–S18. 134 indexed citations

Frid, Anders, Laurence Hirsch, Debbie Hicks, et al.. (2010). The Third Injection Technique Workshop In Athens (TITAN). Diabetes & Metabolism. 36. S19–S29. 20 indexed citations

10.

Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2009). Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial. Lund University Publications (Lund University). 6 indexed citations

11.

Jendle, Johan, Michael A. Nauck, David R. Matthews, et al.. (2009). Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obesity and Metabolism. 11(12). 1163–1172. 247 indexed citations

12.

Hermansen, Kjeld, Michael A. Nauck, Anders Frid, et al.. (2008). Liraglutide, a once-daily human GLP-1 analogue, in type 2 diabetes provides similar glycaemic control with reduced body weight compared with glimepiride when added to metformin. Lund University Publications (Lund University). 2 indexed citations

13.

Jendle, Johan, Michael A. Nauck, D. M. Matthews, et al.. (2008). The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat. Lund University Publications (Lund University). 3 indexed citations

14.

Dorkhan, Mozhgan, Magnus Dencker, & Anders Frid. (2008). Treatment with pioglitazone induced significant, reversible mitral regurgitation. Cardiovascular Diabetology. 7(1). 12–12. 4 indexed citations

15.

Dorkhan, Mozhgan & Anders Frid. (2007). A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes. SHILAP Revista de lepidopterología. 4 indexed citations

16.

Frid, Anders, et al.. (2007). On the effect of a β-glucan enriched oat muesli on blood lipids in healthy subjects with first degree heredity for type 2 diabetes. Lund University Publications (Lund University).

17.

Dorkhan, Mozhgan, Martin Magnusson, Anders Frid, et al.. (2006). Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes. Journal of Internal Medicine. 260(2). 125–133. 16 indexed citations

18.

Frid, Anders, et al.. (2006). Do resource declines increase predation rates on North Pacific harbor seals? A behavior-based plausibility model. Marine Ecology Progress Series. 312. 265–275. 23 indexed citations

19.

Frid, Anders, Mikael Nilsson, Jens J. Holst, & Inger Björck. (2005). Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. American Journal of Clinical Nutrition. 82(1). 69–75. 260 indexed citations

20.

Frid, Anders & Birgitta Linde. (1993). Clinically important differences in insulin absorption from abdomen in IDDM. Diabetes Research and Clinical Practice. 21(2-3). 137–141. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact